Abstract：Objective To explore the effect of Olanzapine in the prevention of vomiting in breast cancer patients treated with Pirarubicin combined with Cyclophosphamide (AC) chemotherapy. Methods A total of 50 breast cancer patients who received AC chemotherapy in Shangrao People′s Hospital from January 2020 to March 2021 were selected as research subjects. They were divided into control group and observation group according to random number table method,with 25 cases in each group. The control group was treated with Ondansetron combined with Dexamethasone for prevention, the observation group was treated with Olanzapine for prevention on the basis of the control group. The acute, delayed complete remission (CR) rates of nausea and vomiting in the first cycle of chemotherapy and expected CR rate of nausea and vomiting in the second cycle of chemotherapy, the total incidence of extrapyramidal reaction after one cycle were compared between the two groups. Results There was no statistical significance in the rate of acute CR in the first cycle between the two groups (P＞0.05). There was no statistical significance in the rate of acute CR in the first cycle,delayed CR in the first cycle and expected CR in the second cycle in the observation group (P＞0.05). There was no statistical significance in the rate of delayed CR in the first cycle and expected CR in the second cycle in the observation group (P＞0.05). The rates of delayed CR in the first cycle and expected CR in the second cycle in the observation group were higher than those in the control group, the differences were statistically significant (P＜0.05). The delayed CR rate of the first cycle and the expected CR rate of the second cycle in the control group were lower than the acute CR rate of the first cycle, the differences were statistically significant (P＜0.05). There was no statistical significance between the delayed CR rate of the first cycle and the expected CR rate of the second cycle in the control group (P>0.05). There was no statistical significance in the total incidence of extrapyramidal reaction between the two groups (P>0.05). Conclusion Olanzapine is effective in preventing delayed and expected nausea and vomiting caused by AC chemotherapy in breast cancer patients, and does not increase the total incidence of extrapyramidal reactions.
韩永清;傅峰;黄开荣▲. 奥氮平在乳腺癌吡柔比星联合环磷酰胺化疗患者呕吐预防中的应用效果[J]. 中国当代医药, 2022, 29(2): 85-88.
HAN Yongqing ;FU Feng ;HUANG Kairong▲. Effect of Olanzapine on preventing vomiting in patients with breast cancer treated with Pirarubicin combined with Cyclophosphamide chemotherapy. 中国当代医药, 2022, 29(2): 85-88.
京公网安备 11010502046607号